Linzess Lawsuit
Serious Dehydration and Kidney Injury from Linaclotide
Linzess (linaclotide) has been linked to severe dehydration and acute kidney injury. If you've been harmed by Linzess, you may have a legal claim.
What Is Linzess?
Linzess (linaclotide) is a medication manufactured by AbbVie designed to treat irritable bowel syndrome with constipation (IBS-C) and chronic constipation.
It works by activating chloride channels in the intestines to increase fluid secretion and bowel movements.
Health Risks and Alleged Injuries
Lawsuits allege that Linzess has caused severe dehydration, electrolyte imbalances, severe diarrhea, and acute kidney injury. Some users report life-threatening complications from overactive bowel responses.
Plaintiffs claim that AbbVie failed to provide adequate warnings about severe dehydration risks and appropriate patient monitoring guidelines.
Litigation Status
Linzess lawsuits have been filed across federal and state courts. The litigation is ongoing with discovery progressing and settlement discussions beginning.
Thousands of individuals have reported serious injuries they attribute to Linzess use.
Who May Qualify
Individuals who took Linzess and subsequently developed severe dehydration, acute kidney injury, or severe electrolyte imbalances may qualify. Medical records documenting these conditions are essential.
You must have used the medication and developed serious health complications during or after treatment.
Next Steps
If you or a loved one took Linzess and suffered serious health problems, contact our firm for a free case review. We will evaluate your claim and explain your legal options.
Time is limited to file claims, so prompt action is essential.
Free Case Review
Learn if you have a claim for Linzess-related injuries.
Start Your ReviewNo fees. No commitments. Confidential.
Key Facts
- GI medication for IBS-C and chronic constipation
- Manufactured by AbbVie
- Linked to severe dehydration and kidney injury
- Active litigation nationwide
The information on this page is for general informational purposes only and does not constitute legal advice.